Neuroimmunomodulation in Depression: A Review of Inflammatory Cytokines Involved in this Process
暂无分享,去创建一个
[1] M. Maes,et al. Increased IL-6 trans-signaling in depression: focus on the tryptophan catabolite pathway, melatonin and neuroprogression , 2013, Pharmacological reports : PR.
[2] H. Hartung,et al. Citalopram suppresses thymocyte cytokine production , 2013, Journal of Neuroimmunology.
[3] Amisha G Patel. Review: the role of inflammation in depression. , 2013, Psychiatria Danubina.
[4] F. Lotrich,et al. Inflammatory cytokines in depression: Neurobiological mechanisms and therapeutic implications , 2013, Neuroscience.
[5] A. Karson,et al. Effects of long-term etanercept treatment on anxiety- and depression-like neurobehaviors in rats , 2013, Physiology & Behavior.
[6] H. Abelaira,et al. Imipramine reverses alterations in cytokines and BDNF levels induced by maternal deprivation in adult rats , 2013, Behavioural Brain Research.
[7] K. Hashimoto,et al. Effects of antidepressants on alternations in serum cytokines and depressive-like behavior in mice after lipopolysaccharide administration , 2013, Pharmacology Biochemistry and Behavior.
[8] J. Suvisaari,et al. Inflammation theories in psychotic disorders: a critical review. , 2013, Infectious disorders drug targets.
[9] P. Moynagh,et al. The Pro-inflammatory Cytokine TNF-α Regulates the Activity and Expression of the Serotonin Transporter (SERT) in Astrocytes , 2013, Neurochemical Research.
[10] J. Hensler,et al. Interleukin-1beta Causes Fluoxetine Resistance in an Animal Model of Epilepsy-Associated Depression , 2012, Neurotherapeutics.
[11] M. Maes,et al. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression , 2012, Neuroscience & Biobehavioral Reviews.
[12] T. Bártfai,et al. IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures , 2011, Brain, Behavior, and Immunity.
[13] J. Suvisaari,et al. Inflammation in psychotic disorders: A population-based study , 2011, Psychiatry Research.
[14] Lisa Goehler,et al. In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[15] J. Kowalski,et al. Interleukin-1beta Promoter (−31T/C and −511C/T) Polymorphisms in Major Recurrent Depression , 2011, Journal of Molecular Neuroscience.
[16] Sang-Il Lee. "Asia Pacific Allergy": A new leap forward , 2011, Asia Pacific Allergy.
[17] S. Sirisinha. Insight into the mechanisms regulating immune homeostasis in health and disease. , 2011, Asian Pacific journal of allergy and immunology.
[18] T. Kircher,et al. Regulatory T cells increased while IL-1β decreased during antidepressant therapy. , 2010, Journal of psychiatric research.
[19] R. Dantzer,et al. Central Administration of Lipopolysaccharide Induces Depressive-like Behavior in Vivo and Activates Brain Indoleamine 2,3 Dioxygenase In Murine Organotypic Hippocampal Slice Cultures , 2010, Journal of Neuroinflammation.
[20] Luís Eduardo Coelho Andrade,et al. Sistema imunitário: Parte I. Fundamentos da imunidade inata com ênfase nos mecanismos moleculares e celulares da resposta inflamatória , 2010 .
[21] L. Rink,et al. Regulatory T cells increased while IL-1beta decreased during antidepressant therapy , 2010 .
[22] Volker Arolt,et al. The Interleukin 1 Beta (IL1B) Gene Is Associated with Failure to Achieve Remission and Impaired Emotion Processing in Major Depression , 2010, Biological Psychiatry.
[23] N. Herrmann,et al. A Meta-Analysis of Cytokines in Major Depression , 2010, Biological Psychiatry.
[24] F. Brennan,et al. Fluoxetine and citalopram exhibit potent antiinflammatory activity in human and murine models of rheumatoid arthritis and inhibit toll-like receptors. , 2010, Arthritis and rheumatism.
[25] A. Scarpa,et al. MeCP2/H3meK9 are involved in IL-6 gene silencing in pancreatic adenocarcinoma cell lines , 2009, Nucleic acids research.
[26] Martin Samuelsson,et al. Interleukin-6 Is Elevated in the Cerebrospinal Fluid of Suicide Attempters and Related to Symptom Severity , 2009, Biological Psychiatry.
[27] R. Yoshimura,et al. Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression , 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[28] H. Hartung,et al. The antidepressant venlafaxine ameliorates murine experimental autoimmune encephalomyelitis by suppression of pro-inflammatory cytokines. , 2009, The international journal of neuropsychopharmacology.
[29] Jing Du,et al. A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder. , 2009, The international journal of neuropsychopharmacology.
[30] I. Goshen,et al. Interleukin-1 (IL-1): A central regulator of stress responses , 2009, Frontiers in Neuroendocrinology.
[31] R. Dantzer,et al. Central nervous action of interleukin‐1 mediates activation of limbic structures and behavioural depression in response to peripheral administration of bacterial lipopolysaccharide , 2008, European Journal of Neuroscience.
[32] F. Holsboer,et al. Depression, comorbidities and the TNF-α system , 2008, European Psychiatry.
[33] I. Goshen,et al. Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression , 2008, Molecular Psychiatry.
[34] G. Zunta-Soares,et al. Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double‐blind, randomized, placebo‐controlled study , 2008, Human psychopharmacology.
[35] M. Molina-hernandez,et al. Antidepressant-like actions of minocycline combined with several glutamate antagonists , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[36] R. Dantzer,et al. Tumor necrosis factor-α-induced sickness behavior is impaired by central administration of an inhibitor of c-jun N-terminal kinase , 2008, Psychopharmacology.
[37] F. Holsboer,et al. Neuronal actions of glucocorticoids: Focus on depression , 2008, The Journal of Steroid Biochemistry and Molecular Biology.
[38] W. Drevets,et al. Sustained Low-Grade Pro-inflammatory State in Unmedicated, Remitted Women with Major Depressive Disorder as Evidenced by Elevated Serum Levels of the Acute Phase Proteins C-reactive Protein and Serum Amyloid A , 2007, Biological Psychiatry.
[39] P. Scully,et al. Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. , 2007, Journal of psychiatric research.
[40] A. Siracusano,et al. Association between enhanced soluble CD40 ligand and proinflammatory and prothrombotic states in major depressive disorder: pilot observations on the effects of selective serotonin reuptake inhibitor therapy. , 2006, The Journal of clinical psychiatry.
[41] A. Young,et al. The dex/CRH test—Is it better than the DST? , 2006, Psychoneuroendocrinology.
[42] R. Dantzer. Cytokine, sickness behavior, and depression. , 2006, Neurologic clinics.
[43] C. Bai,et al. Cytokines and serotonin transporter in patients with major depression , 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[44] R. Duman,et al. TNFα Signaling in Depression and Anxiety: Behavioral Consequences of Individual Receptor Targeting , 2006, Biological Psychiatry.
[45] E. Göka,et al. IL‐6 levels decrease with SSRI treatment in patients with major depression , 2005, Human psychopharmacology.
[46] T. Niewold,et al. Acute phase reaction and acute phase proteins. , 2005, Journal of Zhejiang University. Science. B.
[47] T. Erlinger,et al. Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey. , 2004, Archives of internal medicine.
[48] L. Ferrucci,et al. Inflammatory markers and depressed mood in older persons: results from the health, aging and body composition study , 2003, Biological Psychiatry.
[49] O. Çalıyurt,et al. Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder , 2003, Psychopharmacology.
[50] Viola Vaccarino,et al. Association Between Depression and Elevated C-Reactive Protein , 2003, Psychosomatic medicine.
[51] Michael J. Owens,et al. Treatment of mood disorders , 2002, Nature Neuroscience.
[52] Jerry W Rudy,et al. Memory for context is impaired by a post context exposure injection of interleukin-1 beta into dorsal hippocampus , 2002, Behavioural Brain Research.
[53] A. Nagai,et al. Cytokines, chemokines, and cytokine receptors in human microglia , 2002, Journal of neuroscience research.
[54] M. Bala,et al. Infliximab Improves Quality of Life in Patients with Crohn's Disease , 2002, Inflammatory bowel diseases.
[55] L. Fried,et al. Inflammation and coagulation factors in persons > 65 years of age with symptoms of depression but without evidence of myocardial ischemia. , 2002, The American journal of cardiology.
[56] I. Everall,et al. Expression of β‐chemokines and chemokine receptors in human fetal astrocyte and microglial co‐cultures: Potential role of chemokines in the developing CNS , 2002, Glia.
[57] B. Curran,et al. The pro-inflammatory cytokine interleukin-18 impairs long-term potentiation and NMDA receptor-mediated transmission in the rat hippocampus in vitro , 2001, Neuroscience.
[58] A. Dunn,et al. Behavioral Effects of Cytokines , 2001, Brain, Behavior, and Immunity.
[59] E. Bosmans,et al. Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis , 2001, European Neuropsychopharmacology.
[60] T. Pollmächer,et al. Cytokine-associated emotional and cognitive disturbances in humans. , 2001, Archives of general psychiatry.
[61] T. J. Nickola,et al. Antidepressant Drug-Induced Alterations in Neuron-Localized Tumor Necrosis Factor-α mRNA and α2-Adrenergic Receptor Sensitivity , 2001 .
[62] R. Dantzer. Cytokine‐Induced Sickness Behavior: Mechanisms and Implications , 2001, Annals of the New York Academy of Sciences.
[63] M. Maes. The immunoregulatory effects of antidepressants , 2001, Human psychopharmacology.
[64] R. Yirmiya. Depression in medical illness: the role of the immune system. , 2000, The Western journal of medicine.
[65] R. Dantzer,et al. Role of IL-6 in cytokine-induced sickness behavior a study with IL-6 deficient mice , 2000, Physiology & Behavior.
[66] D. Remick,et al. Cytokines and the brain: implications for clinical psychiatry. , 2000, The American journal of psychiatry.
[67] H. Vedder,et al. Cytokine Production and Treatment Response in Major Depressive Disorder , 2000, Neuropsychopharmacology.
[68] J. W. Rudy,et al. Role of interleukin-1 beta in impairment of contextual fear conditioning caused by social isolation , 1999, Behavioural Brain Research.
[69] J. Levine,et al. Cerebrospinal Cytokine Levels in Patients with Acute Depression , 1999, Neuropsychobiology.
[70] R. Duman. Novel therapeutic approaches beyond the serotonin receptor , 1998, Biological Psychiatry.
[71] E. Bosmans,et al. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. , 1997, Cytokine.
[72] J. Herman,et al. Neurocircuitry of stress: central control of the hypothalamo–pituitary–adrenocortical axis , 1997, Trends in Neurosciences.
[73] R. Spengler,et al. Changes in noradrenergic sensitivity to tumor necrosis factor-α in brains of rats administered clonidine , 1996, Journal of Neuroimmunology.
[74] J. Levine,et al. Possible antidepressant effect of minocycline. , 1996, The American journal of psychiatry.
[75] C. Janeway. Immunobiology: The Immune System in Health and Disease , 1996 .
[76] C. Newton,et al. Spatial Learning Impairment in Mice Infected with Legionella pneumophila or Administered Exogenous Interleukin-1-β , 1995, Brain, Behavior, and Immunity.
[77] Michael Maes,et al. Evidence for an immune response in major depression: A review and hypothesis , 1995, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[78] S. Manuck,et al. Cardiovascular reactivity and the course of immune response to an acute psychological stressor. , 1994, Psychosomatic medicine.
[79] G. Siggins,et al. Interleukin 1β inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus , 1993, Brain Research.
[80] M. Oitzl,et al. Interleukin-1β, but not interleukin-6, impairs spatial navigation learning , 1993, Brain Research.
[81] R. Dantzer,et al. Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[82] R. Dantzer,et al. Effects of lipopolysaccharide on food-motivated behavior in the rat are not blocked by an interleukin-1 receptor antagonist , 1992, Neuroscience Letters.
[83] A. Denman. Cellular and Molecular Immunology , 1992 .
[84] R. S. Smith. The macrophage theory of depression. , 1991, Medical hypotheses.
[85] P. Matangkasombut. Studies of lymphocyte subpopulations and their clinical implications. , 1983, Asian Pacific journal of allergy and immunology.
[86] I. Kushner. THE PHENOMENON OF THE ACUTE PHASE RESPONSE * , 1982, Annals of the New York Academy of Sciences.
[87] A. Kraneveld,et al. The neuro-immune axis: prospect for novel treatments for mental disorders. , 2014, Basic & clinical pharmacology & toxicology.
[88] D. F. Drake,et al. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. , 2013, JAMA psychiatry.
[89] D. Kurcgant,et al. Cytokine profiles in women with different subtypes of major depressive disorder. , 2007, Journal of psychiatric research.
[90] T. J. Nickola,et al. Antidepressant drug-induced alterations in neuron-localized tumor necrosis factor-alpha mRNA and alpha(2)-adrenergic receptor sensitivity. , 2001, The Journal of pharmacology and experimental therapeutics.
[91] C. Janeway,et al. The Immune System in Health and Disease , 2001 .
[92] M. Maes,et al. Major depression and activation of the inflammatory response system. , 1999, Advances in experimental medicine and biology.
[93] S. Maier,et al. Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. , 1998, Psychological review.
[94] P. Gillet,et al. Effects of continuous infusion of interleukin 1 beta on corticotropin-releasing hormone (CRH), CRH receptors, proopiomelanocortin gene expression and secretion of corticotropin, beta-endorphin and corticosterone. , 1997, Neuroendocrinology.
[95] M. Oitzl,et al. Interleukin-1 beta, but not interleukin-6, impairs spatial navigation learning. , 1993, Brain Research.
[96] R. Dantzer,et al. Sickness behavior as a new target for drug development. , 1992, Trends in pharmacological sciences.